Literature DB >> 20477641

Role of B cells in common variable immune deficiency.

Sam Ahn1, Charlotte Cunningham-Rundles.   

Abstract

Common variable immune deficiency is a heterogeneous immune deficiency characterized by reduced serum immunoglobulins and a lack of antibodies. As the name implies, B-cell defects are variably defective. In particular, peripheral blood isotype-switched CD27(+) memory B cells are reduced in number and have been the basis of several classification schemes. A lack of these B cells has been associated with selected clinical conditions, including immune cytopenias, splenomegaly, granulomatous disease and lymphadenopathy. Genetic defects in ICOS, CD19 and TACI have been described. In addition to defects in the production or survival of memory B cells, in most subjects, B cells have defects in Toll-like receptor signaling.

Entities:  

Year:  2009        PMID: 20477641      PMCID: PMC2922984          DOI: 10.1586/eci.09.43

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  80 in total

1.  Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

Authors:  Benjamin L Hsu; Susan M Harless; R Coleman Lindsley; David M Hilbert; Michael P Cancro
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

2.  Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients.

Authors:  Nadine Taubenheim; Marcus von Hornung; Anne Durandy; Klaus Warnatz; Lynn Corcoran; Hans-Hartmut Peter; Hermann Eibel
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

3.  Immune competence and switched memory B cells in common variable immunodeficiency.

Authors:  Jimmy Ko; Lin Radigan; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2005-07       Impact factor: 3.969

4.  Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production.

Authors:  Frédéric Lavie; Corinne Miceli-Richard; Marc Ittah; Jérémie Sellam; Jacques-Eric Gottenberg; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2006-10-13       Impact factor: 19.103

5.  Identification of a subset of common variable immunodeficiency patients with impaired B-cell protein tyrosine phosphorylation.

Authors:  R Schwartz; Y B Porat; Z Handzel; Z Sthoeger; B Z Garty; R Confino-Cohen; J Levy; I Zan-Bar
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 6.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.

Authors:  Hendrik Poeck; Moritz Wagner; Julia Battiany; Simon Rothenfusser; Daniela Wellisch; Veit Hornung; Bernd Jahrsdorfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

8.  Novel mutations in a Japanese patient with CD19 deficiency.

Authors:  H Kanegane; K Agematsu; T Futatani; M M Sira; K Suga; T Sekiguchi; M C van Zelm; T Miyawaki
Journal:  Genes Immun       Date:  2007-09-20       Impact factor: 2.676

9.  Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

Authors:  B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

Review 10.  Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

Authors:  C Bacchelli; S Buckridge; A J Thrasher; H B Gaspar
Journal:  Clin Exp Immunol       Date:  2007-09       Impact factor: 4.330

View more
  20 in total

1.  Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency.

Authors:  Maria J Gutierrez; Kathleen E Sullivan; Ramsay Fuleihan; Clifton O Bingham
Journal:  Semin Arthritis Rheum       Date:  2018-02-23       Impact factor: 5.532

Review 2.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 3.  Autoimmunity in Primary Immunodeficiencies (PID).

Authors:  Grace T Padron; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

Review 4.  B- and T-Cell Subset Abnormalities in Monogenic Common Variable Immunodeficiency.

Authors:  Saba Fekrvand; Shaghayegh Khanmohammadi; Hassan Abolhassani; Reza Yazdani
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

Review 5.  Primary B-cell immunodeficiencies.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Hum Immunol       Date:  2018-10-22       Impact factor: 2.850

6.  Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications.

Authors:  Marylin Desjardins; Marianne Béland; Marieme Dembele; Duncan Lejtenyi; Jean-Phillipe Drolet; Martine Lemire; Christos Tsoukas; Moshe Ben-Shoshan; Francisco J D Noya; Reza Alizadehfar; Christine T McCusker; Bruce D Mazer
Journal:  J Clin Immunol       Date:  2017-11-04       Impact factor: 8.317

7.  A Tale of Two Immunodeficiencies: A Case of Multiple Myeloma Associated with Profound Immune Defect Mimicking Common Variable Immunodeficiency Syndrome.

Authors:  Leonid L Yavorkovsky; Andrew Hope
Journal:  Perm J       Date:  2019-12-06

8.  Combined immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency

Authors:  R Shavit; R Maoz-Segal; S Frizinsky; S Haj-Yahia; I Offengenden; D Machnas-Mayan; Y Tunisky; M Iancovici-Kidon; N Agmon-Levin
Journal:  Clin Exp Immunol       Date:  2021-02-25       Impact factor: 4.330

9.  COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review.

Authors:  Jessica M Jones; Aiman J Faruqi; James K Sullivan; Cassandra Calabrese; Leonard H Calabrese
Journal:  Pathog Immun       Date:  2021-05-14

10.  Common variable immune deficiency in children--clinical characteristics varies depending on defect in peripheral B cell maturation.

Authors:  Barbara Piątosa; Małgorzata Pac; Katarzyna Siewiera; Barbara Pietrucha; Maja Klaudel-Dreszler; Edyta Heropolitańska-Pliszka; Beata Wolska-Kuśnierz; Hanna Dmeńska; Hanna Gregorek; Irena Sokolnicka; Aneta Rękawek; Katarzyna Tkaczyk; Ewa Bernatowska
Journal:  J Clin Immunol       Date:  2013-02-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.